Skip to content

Ritodrine

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: DU21220, lavopa, ritodrine HCl, ritodrine hydrochloride, yutopar

OfmFDA approvedATC G02CA01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ritodrine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1991. DrugCentral lists 2 molecular targets, including ADRB2 and ADRB3. Recorded indications include Premature labor.

  • Approval status: ofm (first approved 1991 by the FDA).
  • Molecular targets: ADRB2 and ADRB3 (2 listed in DrugCentral).
  • Indications: Premature labor.
  • ATC code: G02CA01 (Sympathomimetics, labour repressants).
  • Molecular formula: C17H21NO3; molecular weight 287.36 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Premature labor

Contraindications (15)

  • Antepartum hemorrhage
  • Chorioamnionitis
  • Conduction disorder of the heart
  • Dehydration
  • Eclampsia in pregnancy
  • Fetal death
  • Gestational diabetes mellitus
  • Hypertensive disorder
  • Hypertensive urgency
  • Hyperthyroidism
  • Hypovolemia
  • Migraine
  • Mild pre-eclampsia
  • Pulmonary hypertension
  • Severe pre-eclampsia

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Beta-2 adrenergic receptorADRB2agonistEC50 7.62
Beta-3 adrenergic receptorADRB3unknownEC50 6.72

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1991-01-22FDA—HOSPIRA

ATC classification

ATC codeTherapeutic hierarchy
G02CA01GENITO URINARY SYSTEM AND SEX HORMONES › OTHER GYNECOLOGICALS › OTHER GYNECOLOGICALS › Sympathomimetics, labour repressants

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Premature baby405.3
Low birth weight baby366.0
Foetal exposure during pregnancy309.6
Exposure during pregnancy282.9
Maternal exposure during pregnancy207.2
Premature delivery185.6

Chemical structure

Molecular formulaC17H21NO3
Molecular weight287.36 g/mol
CAS number26652-09-5
InChIKeyIOVGROKTTNBUGK-SJKOYZFVSA-N
PubChem CID33572
C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ritodrine used for?

DrugCentral lists the following indications for Ritodrine: Premature labor.

How does Ritodrine work?

Its molecular targets in DrugCentral include ADRB2 (agonist) and ADRB3.

When was Ritodrine first approved?

Ritodrine was first approved by the FDA in 1991.

What is the chemical formula of Ritodrine?

Ritodrine has the molecular formula C17H21NO3 and a molecular weight of 287.36 g/mol.

Browse: all drugs starting with R · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1991-01-22
AgencyFDA
Targets2
Indications1
FormulaC17H21NO3
DrugCentral ID2390
Interactive profile